Drug Use and Addiction Research Programs - Other Research
Active
- Assistance listing
- 93.DA4
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury accounts
-
- 08-0293-2-0-261
- 08-0293-2-0-251
- 08-0293-2-0-241
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health (NIDA – National Institute on Drug Abuse) funds basic, clinical, translational, and implementation research on substance use, drug addiction, drug overdose prevention, diagnosis, and treatment under Assistance Listing 93.DA4, with scientific review periods ranging from 180 days for AIDS applications to 240–270 days for other submissions.
The program supports research aimed at developing new knowledge and approaches to prevent, diagnose, and treat drug use, misuse, and addiction, and related health outcomes including HIV/AIDS. Funding covers the full spectrum from basic science through clinical translation to implementation-ready interventions. NIDA awards grants directly to applicant institutions after the National Advisory Council on Drug Abuse concurs with Scientific Review Group recommendations and approves funding for payment.
Selection criteria include scientific and technical merit, research feasibility, potential contribution to addressing the national drug use problem, and alignment with NIDA priorities. Renewals are determined at the individual NOFO level; eligible organizations are also specified by NOFO. Non-federal recipients are subject to standard NIH audit requirements under 2 CFR Part 200 Subpart F, with records retained for at least three years (extended if audit findings remain unresolved).
The source does not report recent grant awards, award frequency, funding volumes, typical award magnitudes, or current open grant opportunities. The program description does not specify assistance-type mix or funding concentration patterns. No information is available on the most recent funding activity or active solicitations.
Objective and description
- Objective
To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related
- Description
To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS.
Eligibility
- Applicant eligibility
Eligible organizations determined at the NOFO level
How to apply
- Criteria for selecting proposals
The following considerations will be used in determining projects to be funded: (1) Scientific and technical merit; (2) the feasibility of the research; (3) potential contribution to the national drug use problem; and (4) relevance to NIDA priorities.
- Award procedure
Grants with which the National Advisory Council on Drug Abuse has concurred with the recommendations of the Scientific Review Groups and approved by NIDA for payment are awarded directly by NIDA to the applicant institution.
- Time to approval or disapproval
From 240 to 270 days from submission of grant application. For AIDS applications the range will not exceed 180 days from cited receipt date
- Renewals
Renewals are determined at the NOFO level.
- Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page https://grants.nih.gov/grants/guide/notice-files/not-od-11-064.html, https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-101.html and https://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-003.html
Quick answers
What is Assistance Listing 93.DA4?
Assistance Listing 93.DA4 is Drug Use and Addiction Research Programs - Other Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Drug Use and Addiction Research Programs - Other Research?
Its CFDA number is 93.DA4: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program